True Link Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Hold
954
– – 0.01% 96
2026
Q1
$207K Sell
954
-111
-10% -$24.6K 0.01% 92
2025
Q4
$243K Buy
1,065
+134
+14% +$30.5K 0.01% 96
2025
Q3
$216K Buy
+931
New +$190K 0.01% 87
2025
Q2
– Sell
-1,029
Closed -$216K – 88
2025
Q1
$216K Buy
+1,029
New +$200K 0.02% 89
2022
Q1
– Sell
-750
Closed -$102K – 129
2021
Q4
$102K Hold
750
– – 0.01% 377
2021
Q3
$81K Buy
+750
New +$85.7K 0.01% 405

Other funds holding ABBV

True Link Financial Advisors's ABBV Position: Q2 2026 in Review

True Link Financial Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 954 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #96.

True Link Financial Advisors first reported a position in ABBV in Q3 2021 and has held it in 7 quarters since. The position peaked at $243K in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • True Link Financial Advisors held 954 shares of AbbVie worth $240K as of Q2 2026.
  • True Link Financial Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.01% of True Link Financial Advisors's portfolio in Q2 2026, its #96 holding.
  • True Link Financial Advisors first reported a position in AbbVie in Q3 2021 and has held it in 7 quarters since.
  • True Link Financial Advisors's AbbVie position peaked at $243K in Q4 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on True Link Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.